Immune function in autistic children

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 6, 2005, Pages 558-565

  Stern, Lara ^a   Francoeur, Marie Josée ^a   Primeau, Marie Noel ^a   Sommerville, Wendy ^a   Fombonne, Eric ^a   Mazer, Bruce D ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA ANTIBODY; IMMUNOGLOBULIN E; TETANUS ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; ATOPY; AUTISM; B LYMPHOCYTE; CLINICAL ARTICLE; COMPLEMENT SYSTEM; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; SCHOOL CHILD; T LYMPHOCYTE; VACCINATION;

EID: 29444446363     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61019-8     Document Type: Article

References (52)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
2. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord. 2003;33:365-382.
3. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA. 2001;285:3093-3099.
4. Stubbs EG, Crawford ML. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr. 1977;7:49-55.
5. Stubbs EG. Autistic children exhibit undetectable hemagglutination- inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr. 1976;6:269-274.
6. Warren RP, Margaretten NC, Pace NC, Foster A. Immune abnormalities in patients with autism. J Autism Dev Disord. 1986;16:189-197.
7. Warren RP, Foster A, Margaretten NC. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry. 1987;26:333-335.
8. Warren RP, Cole P, Odell JD, et al. Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry. 1990;29:873-877.
9. Warren RP, Odell JD, Warren WL, et al. Brief report: immunoglobulin A deficiency in a subset of autistic subjects. J Autism Dev Disord. 1997;27:187-192.
10. Yonk LJ, Warren RP, Burger RA, et al. CD4+ helper T cell depression in autism. Immunol Lett. 1990;25:341-345.
11. Gupta S, Aggarwal S, Heads C. Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996;26:439-452.
12. Singh VK, Fudenberg HH, Emerson D, Coleman M. Immunodiagnosis and immunotherapy in autistic children. Ann N Y Acad Sci. 1988;540:602-604.
13. Singh VK, Warren R, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol. 1997;17:88-90.
14. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003;112:e420-e424.
15. Torres AR, Maciulis A, Stubbs EG, Cutler A, Odell D. The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum Immunol. 2002;63:311-316.
16. Warren RP, Singh VK, Cole P, et al. Increased frequency of the null allele at the complement C4b locus in autism. Clin Exp Immunol. 1991;83:438-440.
17. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol. 2002;129:168-177.
18. Money J, Bobrow NA, Clarke FC. Autism and autoimmune disease: a family study. J Autism Child Schizophr. 1971;1:146-160.
19. Dalton P, Deacon R, Blamire A, et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol. 2003;53:533-537.
20. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999;14:388-394.
21. Warren RP, Odell JD, Warren WL, et al. Strong association of the third hypervariable region of HLA-DR beta 1 with autism. J Neuroimmunol. 1996;67:97-102.
22. Wakefield AJ, Puleston JM, Montgomery SM, Anthony A, O'Leary JJ, Murch SH. Review article: the concept of enterocolonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther. 2002;16:663-674.
23. Wakefield AJ, Anthony A, Murch SH, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000;95:2285-2295.
24. Wakefield AJ. Enterocolitis, autism and measles virus. Mol Psychiatry. 2002;7(suppl 2):S44-S46.
25. Uhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol. 2002;55:84-90.
26. Kawashima H, Mori T, Kashiwagi Y, et al. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci. 2000;45:723-729.
27. Plioplys AV. Intravenous immunoglobulin treatment of children with autism. J Child Neurol. 1998;13:79-82.
28. DelGiudice-Asch G, Simon L, Schmeidler J, Cunningham-Rundles C, Hollander E. Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism. J Autism Dev Disord. 1999;29:157-160.
29. McCusker C, Somerville W, Grey V, Mazer B. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency. Ann Allergy Asthma Immunol. 1997;79:145-150.
30. Harbeck RJ, Giclas PC. Diagnostic Immunology Laboratory Manual. New York, NY: Raven Press; 1991.
31. Warren RP, Yonk LJ, Burger RA, et al. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest. 1990;19:245-251.
32. Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology. 2002;45:1-6.
33. Ferrari P, Marescot MR, Moulias R, et al. Immune status in infantile autism: correlation between the immune status, autistic symptoms and levels of serotonin [in French]. Encephale. 1988;14:339-344.
34. Singh VK. Plasma increase of interleukin-12 and interferon-gamma: pathological significance in autism. J Neuroimmunol. 1996;66:143-145.
35. Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology. 1994;29:12-16.
36. Young JG, Caparulo BK, Shaywitz BA, Johnson WT, Cohen DJ. Childhood autism: cerebrospinal fluid examination and immunoglobulin levels. J Am Acad Child Psychiatry. 1977;16:174-179.
37. Renzoni E, Beltrami V, Sestini P, Pompella A, Menchetti G, Zappella M. Brief report: allergological evaluation of children with autism. J Autism Dev Disord. 1995;25:327-333.
38. Zimmerman AW. Commentary: immunological treatments for autism: in search of reasons for promising approaches. J Autism Dev Disord. 2000;30:481-484.
39. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637-641.
40. Taylor B, Lingam R, Simmons A, Stowe J, Miller E, Andrews N. Autism and MMR vaccination in North London: no causal relationship. Mol Psychiatry. 2002;7(suppl 2):S7-S8.
41. DeStefano F. MMR vaccine and autism: a review of the evidence for a causal association. Mol Psychiatry. 2002;7(suppl 2):S51-S52.
42. Afzal MA, Minor PD. Vaccines, Crohn's disease and autism. Mol Psychiatry. 2002;7(suppl 2):S49-S50.
43. Fombonne E, Cook EH. MMR and autistic enterocolitis: consistent epidemiological failure to find an association. Mol Psychiatry. 2003;8:133-134.
44. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001;108: E58.
45. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347:1477-1482.
46. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study [letter]. Lancet. 1998;351:1327-1328.
47. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA. 2001;285:1183-1185.
48. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ. 2001;322:460-463.
49. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000;19:1127-1134.
50. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:2026-2029.
51. Noble KK, Miyasaka K. Measles, mumps, and rubella vaccination and autism [letter]. N Engl J Med. 2003;348:951-954.
52. Campion EW. Suspicions about the safety of vaccines. N Engl J Med. 2002;347:1474-1475.